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and  presentation  of  antigens  on  the  major  histocompatibility  complex  (MHC) 
provide an efficient response against infections. However, this response strongly 
depends on antigen presentation. During inflammation several oxidative reactions 
occur  that  lead  to  the  production  of  oxidants.  Under  these  conditions  protein 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chemically  active  compounds  that  are  often  important  danger  signals  recruiting 





and  that  adaptive  immunity  is  generated  either  in  the  presence  of,  or  directed 
against, those modified proteins.  
Dendritic  cells  (DCs)  and  macrophages  are  specialized  in  effective  capturing, 
processing  and  presentation  of  protein  antigens  in  order  to  activate  adaptive 
immunity, and are therefore  likely to be the main consumers of HOCl modified 




Therefore  this  study  proposes  a  model  where  protein  antigens  undergo 
modification by HOCl produced by neutrophils and in this new chemical form are 
presented  to  adaptive  immunity.  There  are  two  possible  routes  of  protein 
modification.  Firstly,  that  modification  of  protein  antigens  occurs  inside  
the  neutrophil,  and  macrophages  or  DCs  then  phagocytose  dead  neutrophils 
together  with  the  modified  protein  antigens  (Fig  1.1A).  Secondly,  that  HOCl  is 
released from the neutrophil (for example via leakage from the phagosome) and 
modification  of  protein  antigens  occurs  in  the  immediate  vicinity  of  neutrophils 
infiltration.  These  modified  antigens  are  then  taken  up  directly  by 
macrophages/DCs (Fig 1.1B). 
The  proposed  model  is  based  on  earlier  experimental  studies  that  showed  an 
enhanced adaptive immune response to HOCl modified antigens. For example, it 
has been demonstrated that lower concentrations of HOCl oxidized ovalbumin are 
required  to  stimulate  cellular  and  humoral  immune  responses  compared  to  the 
concentrations  of  native  protein  needed  to  achieve  the  same  outcome.  The 
modified form was processed more efficiently by the presenting cell (Marcinkiewicz, 
1991, 1992) which in this instance was a B lymphoma cell line. Similar results have 
been  obtained  using  other  model  proteins  and  other  methods  of  oxidation. 
Oxidation of hen egg lysozyme and bovine α‐lactalbumin, either via chlorination or 
via performic acid, induced higher T cell activation responses when presented by 




















Protein  antigens  are  likely  to  be  exposed  to  HOCl  oxidation  via  two  ways:  (A) 









and  therefore  play  a  critical  role  in  protection  against  pathogens.  However, 
uncontrolled neutrophil infiltration may lead to host tissue damage as observed in 
pathological  sites.  Neutrophils  are  also  an  important  link  between  innate  and 
adaptive immunity. All these aspects are discussed in this chapter.  
1.1.1  NEUTROPHIL HOMEOSTASIS.  


























the  blood  vessels  allows  extravasation  of  neutrophils  into  extravascular  tissues 
where they migrate along the chemoatractant gradient to the site of inflammation 
(or injury).  
Neutrophil  recruitment  is  characterized  by  the  multi‐step  leukocyte  adhesion 




P‐selectin,  E‐selectin  (expressed  by  activated  endothelium)  and  L‐selectin 
(expressed  on  leukocytes)  interact  with  PSGL1  (P‐selectin  glycoprotein  ligand  1) 
expressed  by  most  leukocytes.  Interaction  between  those  molecules  allows 
leukocytes  to  roll  properly  on  the  endothelium.  In  fact,  a  knockout  mice  study 




Both  β1  and  β2  integrins  are  essential  for  neutrophil  recruitment.  Expressed  by 
leukocytes, VLA4 (very late antigen 4 also known as α4β1 integrin) interacts with 
VCAM1  (vascular  cell‐adhesion  molecule  1).  While,  LFA1  (lymphocyte  function 
associate  antigen  1  also  known  as  α1β2  integrin)  supports  rolling  on  ICAM1 
(intercellular adhesion molecule 1). Mice deficient in LFA‐1 (α integrin chain), or in 
CD18 (β2 integrin chain) develop a strong leukocytosis (like to mice deficient  in 
selectins)  (Ding  et  al.,  1999;  Scharffetter‐Kochanek  et  al.,  1998).  In  humans  a 
heterogeneous  mutation  in  CD18  leads  to  leukocyte  adhesion  deficiency  type  I 


















Neutrophils  can  absorb  both  opsonized  and  non‐opsonized  particles.  Opsonized 
particles  are  predominantly  recognized  by  Fc  receptors  (via  binding  to 













bactericidal  mechanisms.  Contrary  to  other  classic  phagocytic  cells  such  as 
macrophages, mature neutrophils do not undergo an active endocytosis. They do 




stages  of  neutrophil  development.  Azurophil  granules  are  formed  first  at  the 
















flavocytochrome  b558  (a  key  component  of  NADPH  oxidase),  IFN‐R1,  CD14  and 
several  other  proteins.  Some  of  these,  that  have  not  yet  been  confirmed  on  a 
protein level but have been shown by gene expression profile during neutrophils 





of  gelatinase  (also  known  as  metalloprotease  9  (MMP9))  (Sengelov,  1993)  and 
leukolysin  (also  know  as  MMP25)  (Kang  et  al.,  2001).  Both  proteases  degrade 
laminin, collagen, proteoglycans and fibronectin hence they play a role in neutrophil 
recruitment (Faurschou, 2003).  
Finally,  specific  granules  and  azurophil  granules  are  mobilized  (with  the  lowest 
potency  to  exocytosis).  Both  granules  contain  essential  bactericidal  proteins. 
Specific  granules  secrete  lactoferrin  (Cramer,  1985;  Sengelov,  1995).  Azurophil 
granules secrete: [1] serine proteases such as neutrophil elastase (Kjell and Inge, 
1974), cathepsin G (Owen and Campbell, 1999) and proteinase 3 (Cramer, 1985), [2] 













the  immune  system  and  help  to  overcome  inflammation.  Activated  neutrophils 
show two characteristic features, firstly, they release a variety of proteases and 
secondly,  they  release  bulk  amounts  of  reactive  oxygen  species  (ROS)  into 
phagosomes. However, it remains open to debate, whether these two factors – 





Production  of  ROS  occurs  during  the  oxidative  burst  reaction  –  a  process 







NADPH  reported  an  associated  massive  efflux  of  H
+  during  respiratory  burst 
(Henderson,  1987).  Hence,  it  is  very  likely  that  the  majority  of  charge  is 
compensated by protons.  
However,  recently,  Reeves  et  al  (2002)  proposed  an  alternative  mechanism 
involving  an  additional  K
+  flux.  In  their  studies,  the  K




























substrate  for  the  myeloperoxidase  enzyme  (which  is  discussed  in  more  
detail below). 
One  product  of  myeloperoxidase  enzyme  activity  is  hypochlorous  acid  (HOCl) 
(Fig.1.4). In addition to HOCl, myeloperoxidase activity catalyses the reactions with 
other  halogens  such  as  Br
‐  and  SCN















Gram‐positive  and  Gram‐negative  bacteria  as  well  as  fungi.  Mice  deficient  in 
neutrophil elastase are more susceptible to infection with Gram‐negative bacteria 
Escherichia coli and Klebsiella pneumoniae (Belaaouj, 1998), and to infection with 
enterobacteria  Shigella  flexneri,  Salmonella  enterica  and  Yersinia  enterocolitica 




a  characteristic  feature  of  Gram‐negative  bacteria  (Belaaouaj  et  al.,  2000).  
In  additon,  neutrophil  elastase  was  shown  to  degrade  a  virulence  factor  of 
enterobacteria (Weinrauch, 2002). On the other hand mice deficient in cathepsin G 
are more sensitive to infection with Gram‐positive bacteria Staphylococcus areus 
(Reeves,  2002).  Finally,  both  enzymes  are  crucial  for  defence  against  fungal 




inflammatory  reaction.  A  recent  study  on  proteinase‐3  and  neutrophil  elastase 
deficient  mice  (Kessenbrock,  2008)  describes  both  enzymes  to  be  involved  in 





that  are  coated  with  proteinase‐3,  neutrophil  elastase,  cathepsins  G  and 
myeloperoxidase released from neutrophils (Birnkmann, 2004). NETs are formed by 
activated  neutrophils  and  play  a  role  as  traps  for  bacteria.  Firstly,  both  Gram‐
positive (S.aureus) and Gram‐negative (S.flexneri) bacteria were shown to associate 














directed  against  MPO  (Falk,  1988),  proteinase  3  (Goldschmeding,  1989)  and 
lysosomal membrane protein‐2 (Kain et al.,  2008). Kessenbrock et al (2009)  has 
shown that in the case of SVV patients, proteinase‐3 and myeloperoxidase normally 





Myeloperoxidase  (MPO)  belongs  to  the  mammalian  haem  peroxidase  enzyme 
family. It is one of the key antimicrobial enzymes involved in oxygen – dependent 
killing  of  pathogens,  and  thus  plays  an  important  role  in  mounting  an  effective INTRODUCTION 
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innate  response  (Klebanoff,  1967).  Like  many  glycoprotein  enzymes,  MPO 
biosynthesis is complex, and includes a series of proteolytic cleavage and processing 
events. The first of these is conversion of the 80kDa primary translation product to 
90kDa  apoproMPO.  There  are  three  distinct  steps  that  are  recognised:  first, 




form  interacts  with  ER  molecular  chaperones  calreticulin  (Nauseef  et  al.,  1995), 
calnexin (Nauseef et al., 1998) ERp57 (Goedken et al., 2007) via the oligosaccharides 
attached  to  the  protein.  These  transit  associations  with  apoproMPO  promote 
proper folding, but it is unclear whether or not they are necessary for the final MPO 
maturation process.  
In  the  ER  the  next  important  event  which  occurs  is  the  insertion  of  the  iron 
containing  (haem)  prosthetic  group.  This  results  in  the  formation  of  
an  enzymatically  active  form,  proMPO  (Nauseef  et  al.,  1992).  Although  haem 
incorporation  is  essential  for  exit  from  the  ER,  and  for  proMPO  reaching  it’s 
destination in the primary granules, the final maturation requires a further series of 
proteolytic  events.  First  a  short  (125  amino  acid)  peptide  is  cleaved  off  from 
proMPO  to  form  a  74kDa  short‐lived  temporary  product  that  can  undergo 
secondary  cleavage  into  a  59kDa  heavy  subunit  and  a  13.5kDa  light  subunit  










Several  possible  outcomes  of  MPO  activation  and  resultant  interaction  with 
hydrogen  peroxide  have  been  investigated.  These  include  the  generation  of 
hypochlorous acid, and resultant chloramines and aldehydes; of hydroxyl radicals; 
of singlet oxygen; and of ozone. 
i.  Hypochlorous  acid.  The  unique  feature  of  MPO  amongst  the  mammalian 
peroxidases is that it is able to catalyse the oxidation of Cl
‐ to HOCl at neutral pH 












H2O2  to  form  the  second  compound  (II),  which  retains  the  oxyl‐ferryl  centre. 
























Other  recent  studies  supported  the  original  view:  for  example,  Davies  et  al  
(Davies,  2008)  observed  that  extracellular  matrix  polysaccharides,  like  heparin 













RCH2NH2 + HOCl ⇒ RCH2NHCl + H2O    [reaction 1.3] 
This reaction is restricted primarily to His, Lys and Arg side chains, together with N‐





aldehydes  are  powerful  bactericidal  MPO‐H2O2‐Cl
‐  end‐products  within  the 
phagosome.  
iii. Hydroxyl radical. The original suggestion about formation of .OH was that this 
was  a  result  of  a  Haber‐Weiss  iron  catalysed  interaction  between  H2O2  and 
superoxide [reaction 1.4] (Haber, 1934).  
H2O2 + O2
 •  ⇒ O2 + OH
- + •OH    [reaction 1.4] 
This  reaction  requires  the  presence  of  free  iron  which  is  present  at  low 
concentrations  in  biological  fluids,  implying  that  formation  of  .OH  via  this 
mechanism  is  limited.  There  is  a  second,  (and  physiologically  more  likely) 





‐ ⇒ HOCl + OH
-      [reaction 1.5] 
HOCl + O2
 • ⇒ •OH + O2 + Cl
‐     [reaction 1.6] 
However, .OH is a major product only if there are no proteins or other biological 
targets  for  HOCl  within  the  phagosome.  Therefore  it  has  been  suggested 
(Winterbourn et al., 2006) that if there is ongoing protein release from either the 
neutrophil or the ingested bacterium then .OH generation via reaction with HOCl 




iv. Singlet oxygen. Singlet oxygen (
1O2) is a highly reactive form of oxygen. Several 
groups have shown that activated neutrophils generate this product in vitro. During 
the  first  minutes  of  an  antimicrobial  response  the  pH  within  the  phagosome 
increases from ~5.7 to 7 (Segal, 1981) and the rate of formation of 
1O2 rises, while 








on  the  potential  targets  of  HOCl  within  the  phagosome  have  shown  that 
1O2 
generation  cannot  compete  with  other  reactions  and  thus 


























of  these  groups  is  complex  and  contains  unstable  intermediates.  For  example, 





























(mouse  tissue  studies  versus  human  peripheral  blood  samples),  mice  have  only  
10‐20% of the MPO activity that is found in humans. Furthermore in the mouse the 




affects  the  binding  of  the  SP1  transcription  factor  (Piedrafita  et  al.,  1996).  




approaches  were  used  to  follow‐up  on  these  studies.  In  one  approach  the 
phagosome content was subjected to careful scrutiny and HOCl was shown to be 
present,  to  be  active  in  chlorination,  and  to  be  effective  in  S.  aureus  killing  
(Chapman et al., 2002). Interestingly using isotopically labelled tyrosine they also 
showed  that  vast  majority  of  chlorination  occurs  on  neutrophil  rather  than  on 
bacterial proteins. The other approach used mice with impaired HOCl synthesis due 
to  deficiency  of  MPO.  These  MPO  deficient  animals  were  more  susceptible  to 
infection and death following Klebsiella pneumoniae infection. (Hirche et al., 2005) 
However, organisms differ in their susceptibility to MPO‐dependent antimicrobial 
killing.  In  a  more  detailed  study  MPO‐knockout  mice  did  have  increased 
susceptibility  to  infections  caused  by  Candida  albicans  (Aratani  et  al.,  1999), 
Candida tropicalis, Trichosporon asahii and Pseudomonas aeruginosa (Aratani et al., 
2000)  whereas  responses  to  S.aureus,  S.  pneumoniae,  Candida  glabrata  and 
Cryptococcus  neoformans  were    comparable  to  those  seen  in  wild‐type  mice 
















Thus,  it  is  probably  true  that  in  MPO‐deficiency  in  humans  impairment  of 
antimicrobial  activity  depends  on  the  pathogen  species.  Moreover,  there  are 
several  MPO‐independent  mechanisms  that  can  compensate  for  absence  of  the 































































































plasmacytoid  DCs  (pDCs)  The  cDCs  are  further  subdivided  into  at  least  three 

























































recognize  dangerous  signals,  typically  associated  with  infection,  that  if  not 




associated  molecular  patterns  (DAMPs))  or  directly  via  pathogen  associated 
molecular  patterns  (PAMPs).  Recognition  occurs  via  germline‐encoded  pattern‐
recognition  receptors  (PRRs)  such  as  Toll‐like  receptors  (TLRs)  and  nucleotide‐





regulated  may  lead  to  un‐controlled  inflammation  and  death  or  chronic 
autoimmune disorders. The relationship between DAMPs and PAMPs is complex 
and still not fully understood. Studies on PAMPs have been performed over several 














proteins  characterized  by  an  extracellular  domain  containing  leucin‐rich‐repeat 












containing  adaptor‐inducing  IFN‐β  (TRIF)  and  TRIF‐related  adaptor  molecule 
(TRAM). In general Myd88 mediates signalling of all TLRs except of TLR3 that is 
controlled  by  TRIF  protein.  TRIF  protein  also  mediates  Myd88‐independent 
signalling of TLR4. The MAL adaptor protein was demonstrated to act only for TLR4 
and for low ligand concentration for the TLR2 signalling cascade (Kenny et al., 2009; 
























































according  to  N‐terminal  domain:  NLRA,  NLRB,  NLRC3‐5  (and  NOD1  and  NOD2), 
NLRP1‐14, NLRX (Ting, 2008). NLRs recognize specific elements of bacterial PGN 
such  as  γ‐D‐glutamyl‐meso‐diaminopimelic  acid  (iE‐DAP)  and  muramyl  dipeptide 
(MDP),  which  activate  NOD1  and  NOD2  respectively  (Chamaillard  et  al.,  2003; 
Girardin et al., 2003a; Girardin et al., 2003b). In addition NAIP5 (NLRB) and IPAF 
(NLRC4)  are  activated  by  flagellin  from  Legionella  pneumophila  and  Salmonella 
typhimurium (Franchi, 2006; Miao, 2006; Ren et al., 2006).  
1.5.1.2  DAMPS 

























to  DAMPs.  In  a  recent  study,  Chen  at  al  (2009)  proposed  a  mechanism  where 









two  common  structures,  polysaccarides  that  are  a  polymeric  carbohydrate 





linked  glucans.  It  was  also  shown  to  recognize  zymosan,  a  stimulatory  cell‐wall 
extract of Saccharomyces cerevisiae that is composed mainly of β‐glucan (Brown, 










Studies  on  mannose  receptor  (MR)  deficient  mice  demonstrated  a  MR  role  in 
antigen  cross  presentation  and  the  activation  of  the  CD8
+  T  cell  response  






to  the  inhibition  of  cell  tumor  growth  (Kretz‐Rommel  et  al.,  2007).  Because  
the biology of human and mouse DC‐SIGN is different, in this study they used a 
mouse model reconstituted with human immune cells. Finally, bone marrow and 
splenic  DCs  derived  from  human  DC‐SIGN  transgenic  mice,  when  exposed  to 
ovalbumin  modified  with  glycan  that  targets  DC‐SIGN  (such  as  Lewis  X  and  B 
oligosaccharides),  were  demonstrated  to  induce  a  strong  CD4
+  T  cell  response  
(Singh et al., 2009).  
















MGL  is  expressed  by  immature  DCs  and  was  demonstrated  to  bind  
GalNAc‐polymers. In contrast, mouse MGL2 receptors are restricted to dermal DCs 














epitopes  on  their  surface  which  are  recognized  by  the  same  receptor  as  oxLDL  
(Chang et al., 1999). Later, other studies confirmed that the uptake of apoptotic 
cells  is  mediated  by  a  lectin‐like  oxidized  LDL  receptor  LOX‐1  (SR‐E)  
(Oka et al., 1998), CLA‐1 (homolg of rodent SR‐BI) (Murao et al., 1997) and CD36 
(SR‐B) (Ren et al., 1995). Moreover, it was demonstrated that CD36 is expressed 
















































distinct  endocytosis  mechanism  that  keeps  antigens  in  early  endosomes  and 
protects  them  from  complete  degradation.  Finally,  particulate  antigens  can  be 
directed either on MHC class I or class II after entering phagosomes.  
Endocytosed antigens are targeted to the endocytic pathway which is composed of 








formed  de  novo  at  the  plasma  membrane  and  undergo  a  series  of  sequential 
fusions with endosomes that lead to phagosome maturation and final fusion with 












not  as  efficient  as  in  macrophages.  Hence  this  finding  indicates  that  another 



















lysosomes  to  macrophages,  contain  significantly  lower  levels  of  proteases  than INTRODUCTION 
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Enzyme  Protease type  Expression  Knockout phenotype 
Lysosomal proteases 
Cathepsin B  Cysteine  B cells, DCs, MΦ  No marked immune‐system 
phenotype reported 




































Cysteine  B cells, DCs  Hemaphagocytic  syndrome 
phenotype;  lower  NK  cell 
activity 
Non‐lysosomal proteases 






TLR1  and  TLR2;  lysosomal 









major  histocompatibility  complex  class  I  (MHC I),  or  class  II  (MHC II).  However, 
because of the focus of this thesis only presentation on MHC class II complex will be 
described further. 





(1)  Exogenous  antigens  are  endocytosed  and  directed  to  endosomes.  (2) 
Fragmented  antigens  are  transported  to  an  MIIC  compartment  containing  MHC 
class  II  molecules  that  are  being  recycled  from  cell  surface  and  transported  by  
the endoplasmic reticulum (ER) system. The MHC class II peptide binding groove is 
occupied  by  the  invariant  chain  (Ii)  that  also  docks  MHC  class  II  to  MIIC  
(3) The Ii region is enzymatically removed and only CLIP Ii is left in the peptide 





































For  MHC  class  II  presentation,  the  delivery  of  an  antigen  in  a  complex  with  a 
mediator of a maturation signal such as TLR‐4 ligand LPS (Blander and Medzhitov, 
2006) led to significantly enhanced antigen presentation.  

















enhance  immune  responses.  So  far,  previous  studies  have  shown  that  HOCl 
modified proteins may show enhanced immunogenicity both in vitro and in vivo 
(Marcinkiewicz,  1991,  1992).  However,  the  mechanisms  behind  these  effects 
remain poorly understood.  






































Fabre,  France)  and  maintained  in  the  same  media  as  the  CHO  cells  and MATERIAL AND METHODS 
 
  68 
supplemented  with  400  μg/ml  hygromycin  B  (HygroGold,  InvivoGen)  used  as  
a selection antibiotic.  
2.2.2.2  T CELL HYBRIDOMAS  










Epitope  specificity  and  MHC  II  haplotype  of  the  ovalbumin  (OVA)  and  hen‐egg 









complete  RPMI‐164  supplemented  with  250nM  323‐339  ovalbumin  peptide  and 
then expanded for 6 days in complete RPMI‐164 supplemented with 10ng/ml of  
IL‐2. The cells were counted, aliquoted and stored at ‐80ºC until required. Before 





Bone  marrow  cells  were  isolated  from  the  femurs  and  tibias.  The  bones  were 
disinfected with 70% ethanol and one end of the bone was cut with scissors, the 
bone  marrow  was  removed  using  IMDM  with  a  1ml  syringe  and  25G  needle.  
The cells were washed once with IMDM and cultured in complete IMDM media 
supplemented with 50µM 2‐mercaptoethanol (Invitrogen) and 20ng/ml of rGM‐CSF  
(Peprotech, U.K.). The  rGM‐CSF was renewed on day 4 of culture. On day  7  of 
culture  cells  were  harvested  and  purified  by  positive  selection  using  magnetic 
CD11c



















































using  a  molar  extinction  coefficient  of  350  M
‐1  cm























and  optionally  with  290μM  ferrous  sulfate  heptahydrate  (FeSO4  •  7H2O)  
(2mM stock was made up fresh). The modified protein was purified and transferred 







in  anhydrous  dimethyl  sulfoxide  (DMSO)  (Acros  organic,  Geel,  Belgium)  were 
prepared  fresh.  Fluorochromes  were  added  slowly  to  the  protein  (50μl  per  

























  were  conjugated  with  fluorescent  beads  (FluoSpheres  sulfate 
microspheres,  1µm,  red  fluorescent  580/605,  Molecular  Probes,  Invitrogen) 





of  1ml.  The  presence  of  the  protein  on  the  beads  was  confirmed  by  SDS‐PAGE 




Carbonyl  groups  were  quantified  by  reaction  with  2,4‐dinitrophenyl‐hydrazine 
(DNPH) (Camlab Chemicals, Cambridge) (Dalle‐Donne et al., 2003). Briefly, protein 
(1mg/ml in HBSS buffer) and a blank control (HBSS buffer) were mixed (1:1,v/v) with 



















































was  preincubated  for  30min  at  room  temperature  with  1μg/ml  of  polymixin  B MATERIAL AND METHODS 
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indicated  concentrations.  After  24  hours,  the  supernatants  were  harvested  and 
















CTLL‐2  cells  constitutively  express  IL‐2  receptor  and  depends  completely  on  the 
presence  of  IL‐2  in  media.    CTLL‐2  cells  were  incubated  with  a  range  of  IL‐2 
concentrations for 24 hours. Cells were cultures for an additional 16 hours with one 









(Profos,  Germany)  or  20µg/ml  EndoGrad  OVACl
I,  or  100ng/ml  LPS  (Salmonella 
abortus equi, Sigma) for 18 hours at 37°C, 5% CO2. As a negative control, DCs were 




CD11c‐PE  (clone  N418),  CD11c‐APC  (clone  N418),  CD11c‐PE‐Cy7  (clone  N418), 




5  /sample)  were  incubated  in  ice‐cold  blocking  buffer  (HBSS,  10%  rat 
serum. 0.1% sodium azide) for 15 min on ice, washed in washing buffer (HBSS, 5% 











using  CellQuest  software,  or  on  a  confocal  microscope  using  Leica  confocal 
software. 
2.6.2  CONFOCAL MICROSCOPY 


















































Protein  samples  were  added  to  an  equal  volume  of  reducing  sample  buffer 




1%  bromophenol  blue  (Sigma).  Before  loading,  the  samples  were  reduced  by 
heating at 95°C for five minutes. Gels were run at 200V in MES  running buffer 
(Invitrogen)  for  45  minutes  at  room  temperature.  Prestained  protein  ladder 
PageRuler plus (Fermentas, UK) was used as the molecular marker. Bands were 





















































Previous  studies  have  shown  that  HOCl  modified  proteins  may  show  enhanced 
immunogenicity both in vitro and in vivo (Marcinkiewicz, 1991, 1992). However,  
the mechanisms behind these effects remains poorly understood. To address this 





heterogeneous  carbohydrate  chain  covalently  linked  to  the  amide  nitrogen  of 
Asn293.  There  are  three  main  forms  of  OVA  containing  two,  one  and  zero 
phosphate groups per molecule at Ser69 and Ser345.  
Importantly, in the old literature the starting codon for Met was not included in 
sequencing  and  so  OVA  was  described  as  consisting  of  only  385  amino  acids. 
Therefore, according to the present method of sequencing where starting Met is 
included, the commonly known OVA epitope p.323‐339 should in fact be named 
p.324‐340.  However,  because  OVA  epitopes  are  named  as  they  were  firstly 






























free  alpha  and  epsilon  amino  side  chains  leads  to  the  formation  of  unstable 







I)  or  high  (OVACl
H).  Protein  modification  was  monitored  by  measuring  the 
formation of aldehyde groups and disappearance of amino groups as described in 
Material  and  Methods.  Increasing  amounts  of  HOCl  induced  a  dose  dependent 
decrease in number of free amino groups (Fig 3.1A) and a dose dependent increase 







HOCl  was  incubated  with  OVA  at  different  concentrations  of  HOCl  (L  –low,  I  –
intermediate, H –high). A. Loss of free amine groups and B. formation of aldehyde 
groups  were  quantified  as  described  in  Material  and  Methods  using  TNBS  and 
DNPH,  respectively.  Results  are  presented  as  the  average  of  three  independent 
experiments ± SEM. Statistical analysis was performed using a 2‐tailed Student’s t 






































enhancing  T  cells  response.  OVACl
I  prepared  at  pH  9.8  did  not  induce  DO11.10 







A.  DO11.10  hybridoma  cells  (2x10















3/well).  The  graph  shows  OT‐II  proliferation  measured  as  thymidine 









Figure  3.3  Protein  modification  in  pH  9.8  does  not  enhance  antigen 
immunogenicity.  
DO11.10  hybridoma  cells  (2x10
4/well)  were  incubated  with  different  OVA 
concentrations  or,  with  different  OVACl
I  concentrations  prepared  at  pH9.8  as 
described  in  Material  and  Methods  and  purified  bone  marrow  derived  DCs 
(5x10






















































4/well).  The  graph  shows  OT‐II  proliferation  measured  as  thymidine 


























The  H2O2  oxidation  reaction  was  performed  in  the  presence,  or  absence  of  the 
metal  iron.  The  level  of  protein  oxidation  was  monitored  by  measuring  the 
appearance of aldehyde groups. For both experimental conditions (with, or without 
metal  iron),  H2O2  treatment  did  not  induce  aldehyde  formation  (Fig  3.6A). 
Furthermore over a wide range of concentrations, 10‐, 100‐ and 1000‐ molar excess 
of the H2O2, neither DO11.10 (Fig 3.6 B) nor OT‐II (Fig 3.6 C) T cells respond to 






A.  3DO18.3  hybridomas  (left)  or  MF2.D9  hybridomas  (right)  (2x10
4/well)  (which 




3/well).  Supernatants  were  collected  after  24  hours.  The  graph  shows  IL‐2 
























A.  H2O2  was  incubated  with  OVA  at  different  molecular  ratio  (10:1,  100:1  and 
1000:1)  in  the  presence  (right)  or, absence  (left)  of  iron.  Formation  of  aldehyde 
groups was quantified as described in Material and Methods using DNPH. Results 
are representative of two independent experiments. B. DO11.10 hybridomas (left) or 
TCR  transgenic  OT‐II  T  cells  (right)  (2x10
4/well)  were  incubated  with  different 
concentrations of OVA or, OVACl
I or, OVA modified with increasing molecular ratios 
of  H2O2  to  the  protein  (OVAH2O2
10,  OVAH2O2
100,  OVAH2O2
1000)  and  purified  bone 
marrow derived DCs (5x10
3/well). Supernatants were collected after 24 hours. The 










Antigen  presenting  cells  can  utilize  several  mechanisms  of  antigen  uptake  and 
processing. Whereas, the uptake of soluble antigens is mediated by constitutive 
macropinocytiosis  or  clathrin‐mediated  endocytosis,  the  uptake  of  particulate 
antigens,  requires  receptor‐mediated  phagocytosis.  Particulate  antigens  are  also 





which  OVA  or,  OVACl
I  were  first  coated  on  1μm  beads.  Western  Blot  analysis 
confirmed that equal amounts of OVA or, OVACl
I were bound to the beads (Fig 3.7). 
In  order  to  facilitate  removal  of  excess  beads  before  addition  of  T  cells,  these 
experiments  were  carried  out  with  adherent  macrophages,  rather  than  the  
non‐adherent DCs. As with the previous experiments using soluble OVA, OVA on 
beads  without  the  presence  of  LPS  was  presented  very  inefficiently,  by  the 






















































once  (C).  Statistical  analysis  was  performed  using  the  two‐way  ANOVA  test. 

















modification.  That  required  a  monitoring  system  to  measure  the  level  of  the 
oxidation. The most general indicator used as a marker of protein oxidation is the 
content of protein carbonyl groups. Protein carbonyls are very stable and easy to 













free  amino  groups  on  the  α‐carbon  and  not  from  chloramines  formed  on  the  
ε‐amino group. As already mentioned OVA α‐carbon is blocked via acetylation of  

























Protein  oxidation  depends  on  a  number  of  experimental  parameters,  which  we 
control in our experiment. The primary factor is the concentration of HOCl but pH, 
temperature and light also play a role. In aqueous solution HOCl partially dissociates 
into  the  hypochlorite  anion  (OCl














hydrochloric  acid  (HCl)  and  chloric  acid  (HClO3),  or  chloride  and  chlorate  anion  









mixture  play  a  critical  role  in  antigen  modification.  Indeed,  when  the  oxidation 





HOCl  concentration  each  time  prior  to  preparation  of  the  modified  antigen. 
However,  as  discussed  above,  HOCl  can  form  other  chemical  species  that  also 
















proposed  model,  HSA  (molecular  weight  67kDa)  and  apo‐A1  (molecular  weight 





HOCl  backbone  amides  and  tyrosine  residues  are  modified.  The  detail  




concentrations  histidine  and  lysine  residues  become  the  target  
(Pattison et al., 2009).  
By combining these data with known OVA structure we can speculate that, high 
concentrations  of  HOCl  lead  to  oxidation  of  tryptophan  (3  per  OVA),  lysine  
(20 per OVA) and tyrosine (10 per OVA) residues and backbone amides and that 

















cross‐reaction  with  SDS.  Therefore  we  can  only  speculate  that  strong  oxidation 








experiments  showed  that  only  OVA  exposed  to  intermediate  concentrations  of 
HOCl  at  the  pH  9,  induces  enhanced  T  cell  responses  to  the  OVA  p.323‐339 
presented by dendritic cells and by macrophages. 
HOCl  is  a  selective  oxidant  that  preferentially  modifies  particular  amino  acids 










We  observed  an  enhanced  T  cells  response  exclusively  to  epitopes  lacking 
methionine  residues;  whereas  HOCl  treatment  inhibited  the  T  cell  response  to 
methionine  containing  epitopes  (recognized  by  MF2.D5  and  3DO.18  T  cell 
hybridomas). HOCl may modify methionine residues directly to form methionine 
sulfoxide  derivatives  and  therefore  block  recognition  of  these  epitopes  by  the  
T cell. This hypothesis could theoretically be explored using mass spectrometry, 


















Jmol:  an  open‐source  Java  viewer  for  chemical  structures  in  








Firstly,  H2O2  may  not  be  a  strong  enough  oxidant  to  modify  OVA  significantly.  
In other words it is not as reactive agent as HOCl. In fact, a lot of studies have 
shown the powerful oxidizing effect of HOCl but not H2O2 in the context of protein 







shown  by  studying  methionine  sulfoxide  reductase  (Msr),  precisely  the  MsrA 
enzyme  (Le  et  al.,  2009).  The  author  demonstrated  that  MsrA  enzyme  can  be 
inactivated  by  high  doses  of  H2O2  and  the  probable  mechanism  underlying  this 
reaction is via the susceptibility to oxidation of catalytic cysteine domain.  
Secondly,  although  both  oxidants  modify  OVA,  only  HOCl  produces  the  specific 
oxidative  modifications  required  to  enhance  the  T  cell  response.  Unfortunately,  
this hypothesis is difficult to validate. The best method that can precisely identify 






















diversity  of  soluble  and  particulate  antigens.  DCs  selectively  express  some 
phagocytic receptors and antigens are taken up in a more selective manner. 




phagosomal  pH  decreases  rapidly  after  antigen  uptake.  This  results  in  total 
degradation  of  the  antigen.  DCs  have  lower  concentrations  of  proteases  
(Delamarre et al., 2005) and have an active system of alkalinization of phagosomes 
(Savina  et  al.,  2006).  This  results  in  much  less  proteolysis  and  only  partial 
degradation of antigens.  
The  alkalinization  mechanism  was  shown  to  be  particularly  important  when 





of  phagocytosis.  Interestingly  in  our  model,  OVACl









In  general,  the  presented  data  suggests  that  the  mechanism  for  enhanced 
immunogenicity of HOCl‐modify antigen applies to both types of antigen presenting 
cells, DCs and macrophages and to both types of antigen, soluble and particulate.  







•  Dendritic  cells  and  macrophages  process  and  present  HOCl‐modified 
antigen with a higher efficiency than native equivalent.  
•  The effects of HOCl are epitope specific. 
•  Both  particulate  and  soluble  HOCl‐modified  antigens  enhance  the  T  cell 
response. 
•  Hydrogen  peroxide  does  not  enhance  antigen  processing/presentation  






DCs  patrol  the  body  tissues  sensing  dangerous  signals  such  as  presence  
of pathogens. Recognition of microbial antigens is mediated by pattern recognition 
receptors  (PRRs)  for  example,  the  intensively  studied  TLRs  (discussed  in  detail  
in Chapter 1). TLRs mediated signaling leads to upregulation of many molecules on 
DCs involved in antigen presentation including MHC and co‐stimulatory molecules. 
The  role  of  PRRs  in  antigen  presentation  has  been  emphasized  in  many  recent 
studies. In addition an important study suggested that antigen processing might 
also absolutely require TLR ligation (Blander and Medzhitov, 2006).  
In  this  thesis  we  describe  a  novel  mechanism  of  antigen  presentation  that  
is independent of TLRs mediated signaling. We used several methods to exclude 
TLR‐4 ligand LPS. Proteins can be purified to remove LPS contamination, or residual 
LPS  can  be  rendered  inactive  by  addition  of  specific  inhibitors,  for  example 
polymyxin B, which is a natural antibiotic that binds and neutralizes Lipid A (a major 
component of LPS).  
Further  evidence  can  be  obtained  from  knockout  studies.  In  the  case  of  TLRs, 
signalling is mediated either by Myd88 or, by TRIF signal adaptor molecule. Myd88 
is an adaptor molecule utilized by all TLRs apart from TLR3 which mediate signal via 







































Bone  marrow  derived  DCs  were  incubated  for  18  hours  with  EndoGrad  OVA 
(20 μg/ml)  or  EndoGrad  OVACl
I  (20 μg/ml,  endotoxin  free)  or  LPS  (100 ng/ml)  or 
media  only  and  then  analyzed  for  CD86,  MHCII  and  CD54  expression  by  flow 
cytometry.  One  representative  experiment  from  three  independent  experiments  




Contamination  of  protein  preparations  with  LPS  would  result  in  an  increase  in 
immunogenicity  of  OVACl















Figure  4.3  Standard  and  endotoxin  free  OVACl









shows  OT‐II  proliferation  measured  as  thymidine  incorporation.  The  results  are 
presented  as  the  average  ±  SEM  [
3H]Thymidine  incorporation  (c.p.m.)  of  the 
triplicate cultures. The experiment was repeated three times. Statistical analysis was 
performed using the two‐way ANOVA test. *P<0.05, **P<0.01, ***P<0.001.  






Specific  LPS  inhibitors  such  as  polymyxin  B  (PMB)  can  efficiently  block  LPS. 
Therefore,  we  have  tested  if  pre‐incubation  of  OVACl
















(Fig  4.4E)  than  without  addition  of  LPS  or,  following  blocking  with  PMB  
(LPS‐PMB‐OVACl
I)  (Fig  4.4F).  Inhibitory  effect  of  LPS  may  be  due  to  the  early 
activation of DCs and in consequence decrease in antigen uptake.  
PMB alone does not have any toxic effect on T cells. Peptide pre‐incubated with 












(100 ng/ml).  The  graph  shows  OT‐II  proliferation  measured  as  thymidine 
incorporation.  The  results  are  presented  as  the  average  ±  SEM  [
3H]Thymidine 
incorporation (c.p.m.) of the triplicate cultures. The experiments were performed 






TCR  transgenic  OT‐II  T  cells  were  incubated  with  p.323‐339  in  the  presence  or 
absence of polymyxin B (100 ng/ml). The graph shows OT‐II proliferation measured 
as  thymidine  incorporation.  The  results  are  presented  as  the  average  ±  SEM 
[
3H]Thymidine incorporation (c.p.m.) of the triplicate cultures. The experiment was 
















derived  DCs  isolated  from  Myd88/TRIF  deficient  mice  (Fig  4.6).  The  absence  of 
these  two  key  TLR  downstream  signalling  adaptor  molecules  did  not  affect  the 
enhanced  processing  and  presentation  of  OVACl





























incorporated  into  the  OVA  preparation  during  the  commercial  isolation  and 
purification  of  the  protein  from  eggs;  second,  LPS  could  be  introduced  in  our 










•  T  cell  activation  assay  using  bone  marrow  DCs  from  Myd88/TRIF  
double knockout mouse. ENHANCED IMMUNOGENICITY OF HOCL MODIFIED OVA IS NOT MEDIATED VIA TLRS. 
 
  126 
All  four  experiments  have  proven  that  OVACl
I  is  not  contaminated  with  LPS  in 
addition the last experiment has shown that the effect of enhanced immunogenicity 
occurs  independently  of  TLRs  signaling.  However,  we  did  not  find  any  strong 






to  be  essential  for  generation  of  stable  MHC  class  II  –  peptide  complexes 
 (Cella et al., 1997). Moreover more recent studies have shown that LPS induced 
DCs  maturation  leads  to  activation  of  a  vascular  proton  pump  that  enhances 
lysosomal acidification required for activation of proteases. This leads to enhanced 










activation  is  the  MHC  class  II  restricted  antigen  profilin,  a  protein  from  ENHANCED IMMUNOGENICITY OF HOCL MODIFIED OVA IS NOT MEDIATED VIA TLRS. 
 
  127 









was  demonstrated  to  be  very  efficiently  loaded  onto  MHC  class  II  molecules 
 (Blander and Medzhitov, 2006). These authors propose that the link between TLR 
ligation and processing may contribute to the mechanisms of selection between self 









absence  of  LPS.  This  study  therefore  suggests  that,  contrary  to  Blander  and 
Medzhitov’s  conclusions,  antigen  processing  of  OVA  is  not  exclusively  TLR 
dependent.  









bigger  (10  and  4.5  µm)  than  used  by  us  (1  µm),  and  have  different  surface 













been  shown  to  efficiently  prevent  HPV  type  16  and  18  infections  
(Paavonen et al., 2007; Paavonen et al., 2009). 





enhances  antigen  processing/presentation  via  a  TLRs  independent  mechanism.  
We  proposed  that  this  novel  mechanism  could  also  be  used  as  a  new,  







lupus  erythematosus  (Hal  Scofield  et  al.,  2005).  The  autoantigens  were 
demonstrated to cluster in a close proximity to the endoplasmic reticulum (ER) and 
nuclear membranes, compartments where extensive generation of reactive species 
takes  place  (Casciola‐Rosen,  1994).  Thus  it  is  tempting  to  speculate  that  strong 













•  Enhanced  immunogenicity  of  HOCl‐modified  antigen  is  triggered  by  















Another  group  of  DCs  subtypes  we  studied  were  isolated  from  mouse  spleen:  
CD8
+  and  CD8
‐  DC  (Proietto  et  al.,  2008).  CD8
+  DC  are  involved  in  antigen  
cross‐presentation  on  MHC  class  I  complexes,  while  CD8




In  order  to  study  in  vivo  antigen  uptake  by  splenic  DCs,  fluorescently  labelled 
antigen was injection  into a mouse. There are  several routes of  in vivo antigen 
administration,  the  most  popular  methods  are  summarized  in  Table  5.1,  and  
the first three are frequently used for mouse. In this study we used intravenous 





Ag  is  delivered  primarily  to 
the spleen; good for soluble 
Ag without adjuvants 
Adjuvant  cannot  be  used; 





















Injection  site  can  ulcerate; 
special  preparation  of  the 
site of injection necessary. 
Intramuscular 
Ag  uptake  into  to  blood 
stream and lymphatics; good 
for  small  Ag;  large  volume 
can be used;  
Injection  site  cannot  be 
monitored 
Table  5.1  Advantages  and  disadvantages  of  different  routs  of  in  vivo  antigen 


















distinctive  fluorescent  dyes  fluorescein  isothiocyanate  (FITC)  that  emits  green 

















































The  uptake  of  OVA  and  OVACl





I‐TRITC  (Fig  5.2).  OVACl


















I  into  the  endocytic  vesicles  inside  the  cells.  Images  showed  
co‐localization of the two fluorochromes in the same compartment, suggesting that 
HOCl‐modification enhances the magnitude of antigen uptake, but does not alter 





I  (Fig  5.5A).  OVA‐FITC  (100 μg/ml)  was  incubated  with  decreasing 
concentrations of unlabelled OVACl
I. The uptake of OVA‐FITC was inhibited by 60% 
for  the  100 μg/ml  OVACl
I  and  gradually  decreased  to  10%  for  100 ng/ml  OVACl
I.  
The  competition  effect  was  not  detectable  for  the  reverse  experiment  where  
OVACl
I ‐FITC (100 μg/ml) was mixed with decreasing concentrations of unlabeled 


























channel  and  it  is  one  representative  experiment  from  three  independent 
experiments.  Statistical  analysis  was  performed  using  the  Student’s  t  test,  for  
OVA P<0.05, for OVACl












figure  shows  a  representative  low  power  (upper  row)  image,  and  a  high power 
image (lower row) of a cell, which has taken up both antigens. The experiment was 
repeated three times.  
























assessed  by  flow  cytometry  analysis  (Fig  5.7A).  Both  OVA  and  OVACl
I  could  be 
detected  within  splenic  CD11c
+  DC.  There  was a  moderate  enhancement  in  the 
uptake  of  OVACl








The  immunogenic  properties  of  OVACl

































































concentrations  of  OVA  or  OVACl
I  and  TCR  transgenic  OT‐II  T  cells  (2x10
4/well).  
The  graphs  show  OT‐II  proliferation  measured  as  thymidine  incorporation.  
The results are presented as the average ± SEM [
3H]Thymidine incorporation (c.p.m.) 
of  the  triplicate  cultures.  The  experiment  was  repeated  three  times.  Statistical 






that showed the presence of a  receptor  for the oxidised  form, as compared to  

























It  has  already  been  shown,  by  our  laboratory  that  cells  treated  with  HOCl  are  
taken up more efficiently by DCs than non‐treated cells (Chiang et al., 2006). In our 
studies,  we  demonstrated  the  enhanced  uptake  of  HOCl‐modified  glycoprotein 
antigen.  
We  have  explored  the  nature  of  antigen  uptake  using  three  independent 
approaches:  firstly,  antigen  uptake  competition  between  native  and  modified 
antigen measured by flow cytometry; secondly, antigen uptake at low temperature 
measured  by  flow  cytometry;  thirdly,  direct  measurements  of  binding  strength 
between antigen and cell evaluated by atomic force microscopy.  
Firstly, antigen uptake was quantified by flow cytometry. DCs were incubated with 
decreasing  concentration  of  antigen.  Both  native  and  oxidized  antigens  were  
taken up by DCs but native OVA uptake fell sharply at 10μg/ml while OVACl
I uptake 
was  detectable  at  concentrations  as  low  as  0.1μg/ml  (similar  to  the  active 
concentrations observed in the functional assay, chapter 3).  
Secondly,  in  order  to  test  the  nature  of  OVA  uptake  we  have  carried  out 
experiments  at  4°C.  It  has  been  already  shown  that  at  low  temperature  DCs 
endocytic  activity  is  blocked  and  thus  also  the  ability  to  take  up  antigens  
(Sallusto,  1995).  Indeed,  at  4°C  we  have  observed  significantly  reduced  antigen IN VITRO AND IN VIVO STUDIES ON OVACLI UPTAKE AND PROCESSING. 
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we  cannot  rule  out  that  cell  surface  binding  is  also  temperature  dependent.  
In future, it would also be interesting to determine the extent of cell surface versus 
internalised  protein  uptake  at  37°C.  One  approach,  for  example,  would  be  to 








single  molecule  binding  events.  The  AFM  measurement  was  done  by  our 

















is  also  provides  information  about  binding  properties  of  biological  systems.  For 
example  it  has  been  used  in  the  characterisation  of  RAG  synaptic  complex 
(Shlyakhtenko et al., 2009); in study of the Syk kinase dependent signalling in DC 
mediated via crystals binding to lipid membrane (Ng et al., 2008); and in studies on 
the  interaction  of  human  rhinovirus  interaction  with  cell  surface  receptors 
 (Rankl et al., 2008). 
In  our  model,  a  direct  measurement  using  AFM  showed  that  enhanced  antigen 



















lack  of  response  to  OVACl










reduction  of  the  adhesion  probability  factor  (Appendix  A).  This  demonstrates  
the  saturation  effect  where  the  receptor  which  mediates  OVACl
I  uptake  is  dose 
dependently  engaged  by  increasing  concentrations  of  OVACl
I.  In  conclusion  AFM 






















within  cytoplasm  organelles  (endosome‐like)  confirming  the  intracellular 
localization of antigen. However, for future work it will be necessary to determine in 
which  compartments  the  antigens  are  more  exactly  and  if  both  antigens  are 








scavenger  receptors  and  transferrins  taken  up  via  transferrin  receptors. 
Simultaneous incubation of OVA/OVACl
I with one of the proteins (both labeled with 






fluorescence  (spectrum  depends  on  the  dot  size)  and  can  be  conjugated  with 
proteins. Because of their optical properties, two‐photon microscopy can be used to 
visualize quantum dot‐protein conjugates. A recent study has shown DCs in the 
lymph  nodes  containing  quantum  dots  captured  after  subcutaneous  injection  
(Sen  et  al.,  2008).  However,  this  prospective  technique  has  a  disadvantage.  
OVA conjugated with quantum dots induced enhanced T cell responses comparing 




have  focused  on  two  new  experimental  approaches.  First  we  examined  in  vivo 
antigen  uptake  by  splenic  DCs,  and  second  we  examined  the  ex  vivo  capability  







Work  with  splenic  mouse  DCs  leads  to  two  important  problems.  Firstly,  
the procedure used to isolate DCs can favor a particular subtype of DCs. We have 
isolated  cells  by  the  preparation  of  single  cell  suspension  using  the  enzymatic 













expression  (high  F4/80  and  Cd11b  and  low  CD11c)  and  morphology  resemble 
macrophages (Vremec, 2000). Macrophages are well known potent phagocytic cells 




However,  as  we  have  already  mentioned,  DCs  were  enriched  on  CD11c
+  beads 
resulting  in  a  >90%  CD11c
+  population.  Hence,  the  contamination  with 
autofluorescent  cells  in  analyzed  samples  should  be  in  fact  minimal.  Indeed,  
we have observed the presence of very small subpopulation of autofluorescence 
cells that could be detected in all fluorescence channels.  









different  time  points,  early  after  30  minutes  and  late  after  18  hours.  We  also 











are  specialized  in  presentation  on  MHC  class  II  complex  (Dudziak  et  al.,  2007). 
Moreover, several studies have already demonstrated in vivo antigen uptake by 
both DCs subtypes. Just to mention few examples, uptake of necrotic cells material IN VITRO AND IN VIVO STUDIES ON OVACLI UPTAKE AND PROCESSING. 
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(Sancho  et  al.,  2009),  apoptotic  cells  (Morelli  et  al.,  2003),  tumor  cells  










observed  in  vitro  OVACl































to  proteolysis  correlates  with  antigen’s  immunogenicity.  They  have  used  two 
different antigens (each in a more stable or more susceptible form to lysosomal 









































of  chloramines  (discussed  in  chapter  3).  Previous  studies  have  proposed  that 









within  the  hydrophobic  core  of  the  protein  and  thus  extensive  proteolysis  is 
required to release this sequence for further processing. Enhanced proteolysis could 
therefore  result  in  enhanced  processing  and  presentation  of  this  epitope.  
In addition the in vivo studies, which demonstrated disappearance of OVACl
I‐FITC 
after  18  hours  post‐injection,  could  also  be  explained  by  faster  processing  and 







sialic  acid  moieties  (SA)  (Lattova  et  al.,  2004)  although  the  extent  of  sialation 
remains unclear.  
Components of the side chain may be important in immunogenicity. For example 
mannose  residues  are  recognized  by  the  mannose  receptor  that  has  been 
demonstrated to play an important role in uptake of antigen for presentation on 











are  many  potential  candidates  that  are  known  to  be  involved  in  antigen 
presentation (discussed in detail in chapter 1). In this project we have tested one, 




















































I  sample  did  not  reverse  the  enhancement  in  the  T  cell  response.  
Bone  marrow  derived  DCs  co‐cultured  with  decreasing  concentrations  of  
NaBH4‐treated  OVACl
I  (redOVACl
I)  induced  strong  DO11.10  T  cell  hybridoma 
responses (Fig 6.2C). Hence, in contrast to previous studies aldehydes groups were 
not required for the HOCl induced enhancement of the response.  





that  oxidation  altered  protein  conformation  allowing  access  to  previously 
inaccessible amine side chains. Like aldehyde groups, chloramines were also not 
required  for  HOCl  induced  enhancement  of  the  response,  since  reduction  with 
methionine  did  not  reverse  enhanced  T  cell  responses  (Fig  6.2C).  OVA  peptide  















respectively.  The  results  are  presented  as  the  average  of  three  independent 
experiments ±SEM. C. and D. DO11.10 hybridoma cells (2x10
4/well) were incubated 
with  decreasing  concentrations  of  OVA,  mOVACl
I,  redOVACl








































Even  though  protein  oxidation  with  HOCl  induced  increased  susceptibility  to 
proteolysis  by  cathepsin  E,  OVACl
I  processing  and  presentation  was  efficiently 
blocked  by  the  cathepsin  D/E  inhibitor  MPC6  that  was  shown  to  inhibit  OVA  





Figure  6.3  An  intermediate  concentration  of  HOCl  does  not  induce  protein 
fragmentation. 









graph  shows  IL‐2  release  measured  as  thymidine  incorporation  of  the  CTLL2 





was  stained  with  silver  stain  as  described  in  Material  and  Methods.  No  small 
molecular weight fragments were visible. 








Materials  and  Methods,  and  analyzed  by  4‐12%  gradient  denaturing  PAGE. 
Histograms show the degree of proteolysis quantified by comparing the intensity of 
the  OVA  bands  before  and  after  digestion  using  densitometry  as  described  in 
Material and Methods. Statistical analysis was performed using a 2‐tailed Student’s 














T  cell  hybridomas  (2x10
4/well).  Supernatants  were  collected  after  24  hours.  
The graph shows IL‐2 release measured as thymidine incorporation of the CTLL2 




































I  were  both  treated  with  endoglycosidase  F  (PNGase‐F),  which 












equivalents  without  PNGase‐F  and  cultured  with  TCR  transgenic  OT‐II  T  cells. 
Enzyme  treatment  had  no  effect  on  the  presentation  of  OVA,  but  abolished 
completely the enhancement observed after HOCl‐treatment (Fig 6.7B). PNGase‐F 
had  no  toxic  effect  on  the  cells;  p.323‐339  pre‐treated  with  PNGase‐F  or  the 
reaction buffer induced as good T cell response as non‐treated control (Fig 6.7C). 












































units)  or  G7  reaction  buffer  (2μl).  The  experiments  were  repeated  three  times. 






























Figure  6.8  Oxidation  of  nonglycosylated  protein  antigen  does  not  induce  an 
enhanced T cell response.  
HEL  was  oxidized  with  low  (HELCl
L),  intermediate  (HELCl
































were  incubated  with  100 μg/ml  of  OVA‐FITC  or  OVACl















30  minutes  the  excess  antigen  was  removed,  and  the  cells  were  fixed  in  3.8% 
formaldehyde and analyzed by flow cytometry. The results are expressed as median 
fluorescent  intensity  in  the  FITC  channel  and  are  one  representative  from  three 
independent experiments performed. B. CHO cells expressing LOX‐1 were incubated 
with  OVA‐FITC  or  OVACl










mediate  the  enhanced  immunogenicity  of  a  HOCl‐modified  protein  antigen.  
We studied four possible alternatives, discussed in detail below.  
Firstly, we studied the immunological outcome of chemical modification induced by 





enhanced  immunogenic  properties  compared  to  native  protein  (Allison,  2000).  
In  addition,  more  recent  studies  by  Moghaddam  et  al  (2006)  have  shown  that 
treatment  of  proteins  by  formaldehyde,  which  has  been  used  in  preparation  of 
vaccines for many decades, can enhance the  immune response via introduction of 
aldehyde groups into the protein. In order to test the contribution of aldehyde in 
our  model,  we  have  compared  the  T  cell  response  to  oxidized  OVA  (containing 
aldehyde) with the response to reduced OVA (aldehyde free). Reduced OVA was 
first  oxidized  with  HOCl  and  then  treated  with  reducing  agent.  Thus  the  only 
difference  between  these  two  samples  was  the  presence  of  aldehyde  groups.  
The samples were reduced with sodium borohydride (NaBH4). The reaction leads to 







both  oxidized  and  reduced  OVA  enhanced  the  T  cell  response  to  the  323‐339 
epitope.  As  we  discussed  in  chapter  5  OVACl
I  induces  both  enhanced  T  cell 
responses and in vivo humoral responses; while the study on glycolaldehyde treated 
proteins  was  mainly  focused  on  antibody  response  and  hence  may  relate  to 
different mechanism. In addition, the previous studies have focused on protocols, 
which add multiple aldehyde groups to proteins; in contrast, reaction with HOCl 








order  to  be  presented  since  treatment  with  HOCl  does  not  lead  to  protein 
fragmentation.  In  addition  OVACl
I  processing  is  similar  to  native  OVA  (since 
processing of both was blocked effectively by cathepsins D/E inhibitor).  
Enhanced susceptibility to proteinases is not associated invariably with increased 






for  T  cell  recognition  but  that  antigen  presentation  was  in  fact  improved  when  
a  major  aspartyl  protease,  Cathepsin  D,  was  inhibited  (Catherine   et  al.,  2005). 




demonstrated  that  short‐course  treatment  of  mice  with  chloroquine  improved  
CD8
+ T cell priming against soluble antigen (Garulli et al., 2008). Chloroquine is a 
lysosomotropic  agent  that  inhibits  lysosomal  acidifications  and  de  facto  inhibits 
protease activity. Hence, these studies support the view that limiting proteolysis 
can promote T cell responses.  
However,  many  examples  showing  the  requirement  for  proteolysis  in  antigen 




paper  Moss  et  al  (2007)  further  explore  this  observation.  They  found  that  low 
concentrations of AEP lead to cleavage in three residues while high concentrations 
cleaved at six residues and that this correlates with enhanced antigen presentation. 















since  a  direct  causal  link  between  proteolysis  and  presentation  is  not  shown.  
In addition, as discussed in chapter 5, FITC may be quenched/removed from the 












with  HOCl  the  structure  is  more  “relaxed”  and  “open”  and  thus  more  cleavage 
residues are accessible for the enzyme. Secondly, the pattern of N‐glycosylation has 
been  shown  to  regulate  protein  proteolysis  (Cheng‐Chih  et  al.,  2009).  Since  we 






mechanism  that  can  control  ligand‐receptor  interactions  and  this  happens  by 
blocking an interaction between the two molecules. Two examples, the endothelial 
hyaluronan  receptor  LYVE‐1  was  silenced  functionally  (in  vitro  and  in  vivo)  by 
reversible  terminal  sialation  which  led  to  inhibition  of  hyaluronan  binding 
(Nightingale  et  al.,  2009).  In  another  study  on  pathogenesis  of  Haemophilus 
influenzae  infection  sialation  of  LPS  from  H.  influenzae  protects  from  killing  by 
human sera (Derek et al., 1999).  





I  carbohydrate  chain  more  accessible  for  DCs  recognition  and  as  
a  consequence  enhanced  antigen  uptake.  This  hypothesis  could  be  tested  by 
specific removal of sialic acid residues from native OVA, which would be expected 
to  induce  enhanced  T  cell  responses.  Response  to  OVACl
I  treated  with  enzyme 
should not be changed.  
Native  OVA  was  treated  with  neuraminidase  (NA)  that  cleaves  off  α2‐3  and  
α2‐6 linked sialic acid residues. Removal of sialic acid can be confirmed by Western 
blot,  isolectric  focusing  or  mass  spectrometry.  Western  blotting  was  used,  but 


















range  of  oxidized  products,  such  as  N‐chlorosulphonamides  and  chloramides.  
Thus  the  carbohydrate  side  chain  in  OVACl
I  may  contain  a  very  high  density  of 











Carbohydrate  residues  can  be  specifically  removed  from  proteins  by 
endoglycosidase PNGase F. PNGase F cleaves between the asparagine residues and 
inner GlcNAc as shown on Fig 6.1 (Maley et al., 1989) leading to complete removal 













used  as  a  model  antigen.  There  are  several  available  T  cell  hybridomas  that 
recognize different HEL epitopes (Drakesmith et al., 1998). In our study, we tested 
the  response  to  HEL  epitope  71‐85  recognized  by  AD71  T  cell  hybridomas. 
Importantly,  the  epitope  we  chose  did  not  contain  methonine  residues  and 
therefore the possibility that lack of enhanced T cell responses is due to oxidized 
methonine residues could not be excluded (discussed in chapter 3).  












when  the  modified  carbohydrate  chain  mediates  antigen  uptake  by  a  specific, 













































































2004);  (5)  LOX‐1  SR  was  demonstrated  to  mediate  antigen  cross‐presentation 




















•  Neither  aldehyde  nor  chloramine  groups  are  essential  for  the  enhanced  
T cell response to OVACl
I.  


















TLRs  signaling  and  does  not  lead  to  DCs  maturation.  On  the  other  hand, 
enhancement  is  mediated  by  the  N‐linked  carbohydrate  side  chain  of  OVA.  
HOCl‐modified protein is taken up more efficiently by DCs and is also digested more 




This  study  was  based  on  earlier  findings  (Marcinkiewicz,  1991,  1992)  which 
demonstrated  that  protein  chlorination  facilitates  recognition  by  APCs  and  thus 
enhances the immune response.  
The data presented in chapter 3 shown that, indeed optimal concentration of HOCl 
enhanced  immunogenicity  of  model  antigen  OVA.  Both  DCs  and  macrophages 
processed and presented oxidized OVA to DO11.10 and TCR transgenic OT‐II cells 
with increased efficiency. However, the effect was strictly epitope specific and the 




For  DO11.10  hybridoma  cells,  HOCl  treatment  was  necessary  to  obtain  antigen 




treated  with  high  ratio  of  HOCl  reduces  responses  to  all  tested  T  cells.  





with  HOCl  modified  antigen  differ  from  published  earlier  data  (Blander  and 
Medzhitov,  2006)  indicating  a  requirement  of  TLRs  pathway  in  efficient  antigen 
processing of unmodified OVA.  
Our study has at least two important implications. Firstly, treatment with HOCl may 
be  useful  as  a  new  vaccination  strategy.  Secondly,  HOCl  may  be  involved  in 








receptor  mediated  and  is  due  to  stronger  protein  binding  to  the  cell  surface. 







proteases.  Because  other  recent  study  presented  an  opposite  hypothesis 














was  compared  only  to  H2O2,  but  obviously  other  oxidants  should  be  used  for 
example products of nitrogenation.  























HOCl  is  a  very  promising  target,  its  strong  immunogenic  effect  decreases  the 
amount of antigen used; and since it is naturally present in humans (as a product of 
neutrophils) allergic side effects should be minimal.  
The  uptake  studies  are  obviously  related  to  identification  of  specific  receptors, 
which  bind  HOCl‐modified  OVA.  Here  only  the  LOX‐1  receptor  was  tested  but 
broader receptor screening is required. This study would include in vitro screening 
of stably transfected cell lines with selected candidates, but also in vivo studies 
using  knockout  mice,  for  example  mice,  which  do  not  express  the  mannose 
receptor. In order to obtain a list of selected candidates detailed studies of the 
carbohydrate  side  chain  have  to  been  done.  As  shown  in  chapter  6,  the  HOCl 
enhanced effect is true only for glycosylated proteins like OVA. Detail information 
about  glycoproteins  can  be  obtained  for  example  by  mass  spectrometry  using 
Matrix  Assisted  Laser  Desorption  Ionisation  (MALDI)  technique,  or  by  less 





and  internalized  antigen;  secondly,  analysis  of  the  lysosomal  compartment 
containing  internalized  antigen  in  the  context  of  active  proteases.  Other  work SUMMARY. 
 
  194 
would  include  a  comparison  of  native  and  modified  OVA  localization  inside  the 
different endocytic compartments and analysis of the kinetics with which antigens 
are processed through these compartments. Finally the processing of modified OVA 










earlier  work  and  deals  in  detail  with  possible  mechanisms  controlling  the 
immunogenic effect of HOCl. The study was done at different experimental levels 
including  biochemical  studies,  in  vitro  analysis  and  in  vivo  analysis.  HOCl  or  its 
derivatives may be a possible candidate for a new approach to adjuvanticity in the 
absence of TLR or NLR ligands. Further studies will be required to fully understand 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